Development of a FibroScan Liver Examination Using a Single Probe
ConditionLiver Diseases
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorEchosens
About this trial
This is an exploratory, international, prospective, interventional, multicenter clinical investigation that will take place in 1 Hong Kong site and 3 French sites and 309 adults patients will be included. The study objective is to assess the LSM reproducibility between the FibroScan examination performed with the Single Probe (SP) and the FibroScan examination performed with the reference probes (M and XL).
Eligibility criteria
Qualifiers
Adult patients (≥ 18 years of age).
Patient followed with a chronic liver disease.
Adult patient able to give his written consent.
For European sites: patient affiliated to the healthcare system.
Disqualifiers
Vulnerable patients.
Patients with ascites.
Patients with heart failure.
Patients with acute hepatitis.
Trial design
Treatments tested in this trial
- Research FibroScan
Treatment groups
309 Participants
are divided into 1 treatment groupSponsors and collaborators
Echosens
Lead sponsor
Novotech CRO
Collaborator
Source ClinicalTrials.gov